Literature DB >> 3280602

Characterization of the thyroid microsomal antigen, and its relationship to thyroid peroxidase, using monoclonal antibodies.

L Portmann1, F W Fitch, W Havran, N Hamada, W A Franklin, L J DeGroot.   

Abstract

MAb directed to the thyroid microsomal antigen have been developed. All bound to 101- and 107-kD bands in Western blot analysis using thyroid microsomal fraction as antigen. The MAb also bound to microsomal proteins immunoprecipitated by serum from patients having a high titer of anti-microsomal antibody but no antibodies to thyroglobulin or thyrotropin-stimulating hormone receptor. The pattern of binding was related to the amount of reducing agent. The 101- and 107-kD bands were increased by addition of dithiothreitol whereas, in its absence, numerous bands of higher molecular weight were present, suggesting a multimeric protein structure. Despite the inability to immunoprecipitate thyroid peroxidase (TPO) enzymatic activity, the MAb bound intensively in Western blot to denatured purified hog TPO and to denatured immunopurified human TPO. Trypsin digestion of the 101-107-kD antigen produced a doublet of 84-88 kD that was still immunoreactive with MAb. One of five polyclonal sera tested (with a microsomal antibody titer greater than 1/20,480 measured by the tanned red cell hemagglutination technique) also recognized the 84-88 kD trypsin fragments. Addition of V8 protease led to a disappearance of the 107-kD protein, but not the 101-kD protein, proving that this antigen is formed by two different polypeptides. The MAb bound strongly to thyroid epithelium, whereas binding to papillary carcinoma was absent or low and moderate for follicular and Hurthle cell carcinoma. This study indicates that the thyroid microsomal antigen and TPO are identical and are constituted of two different polypeptides. On SDS-PAGE the antigen appears as two contiguous bands which share common epitopes but are not identical, as proven by their size and difference in susceptibility to proteolytic digestion. The immunoreactivity of the molecule is highly dependent on a trypsin-sensitive site, which appears important in the recognition of the antigen by polyclonal sera and may have biological importance. The expression of microsomal antigenicity is variable among various thyroid carcinomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280602      PMCID: PMC329652          DOI: 10.1172/JCI113438

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

1.  THE CYTOPLASMIC AUTO-ANTIGEN OF THE HUMAN THYROID. I. IMMUNOLOGICAL AND BIOCHEMICAL CHARACTERISTICS.

Authors:  I M ROITT; N R LING; D DONIACH; K G COUCHMAN
Journal:  Immunology       Date:  1964-07       Impact factor: 7.397

2.  Cytoplasmic localization of "complement-fixing" auto-antigen in human thyroid epithelium.

Authors:  E J HOLBOROW; P C BROWN; I M ROITT; D DONIACH
Journal:  Br J Exp Pathol       Date:  1959-12

3.  Reductive cleavage of cystine disulfides with tributylphosphine.

Authors:  U T Rüegg; J Rudinger
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

4.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

5.  Selective suppression of reactivity to rat histocompatibility antigens by hybridoma antibodies.

Authors:  T J McKearn; M Sarmiento; A Weiss; F P Stuart; F W Fitch
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

6.  Hog thyroid peroxidase: physical, chemical, and catalytic properties of the highly purified enzyme.

Authors:  A B Rawitch; A Taurog; S B Chernoff; M L Dorris
Journal:  Arch Biochem Biophys       Date:  1979-04-15       Impact factor: 4.013

7.  A better cell line for making hybridomas secreting specific antibodies.

Authors:  M Shulman; C D Wilde; G Köhler
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

8.  Solubilization of human thyroid microsomal antigen.

Authors:  S Mariotti; A Pinchera; C Marcocci; P Vitti; C Urbano; L Chiovato; M Tosi; L Baschieri
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

9.  Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases.

Authors:  N Amino; S R Hagen; N Yamada; S Refetoff
Journal:  Clin Endocrinol (Oxf)       Date:  1976-03       Impact factor: 3.478

10.  Presence of the organ-specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity.

Authors:  E L Khoury; L Hammond; G F Bottazzo; D Doniach
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

View more
  4 in total

1.  Thyroid peroxidase in endemic goiter tissue.

Authors:  M Sugawara; C N Summer; A Kobayashi; S Murakami; K Kuma; G A Medeiros-Neto
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

2.  Generation of recombinant, enzymatically active human thyroid peroxidase and its recognition by antibodies in the sera of patients with Hashimoto's thyroiditis.

Authors:  K D Kaufman; B Rapoport; P Seto; G D Chazenbalk; R P Magnusson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  Detection of Leu-19 (CD56) antigen on human thyroid epithelial cells by an immunohistochemical method.

Authors:  K Migita; K Eguchi; A Kawakami; H Ida; T Fukuda; A Kurata; N Ishikawa; K Ito; S Nagataki
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

4.  Recognition by recombinant autoimmune thyroid disease-derived Fab fragments of a dominant conformational epitope on human thyroid peroxidase.

Authors:  S Portolano; G D Chazenbalk; P Seto; J S Hutchison; B Rapoport; S M McLachlan
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.